AVXL
Price
$8.35
Change
-$0.33 (-3.80%)
Updated
Feb 21 closing price
Capitalization
710.29M
74 days until earnings call
IDYA
Price
$21.85
Change
+$0.12 (+0.55%)
Updated
Feb 21 closing price
Capitalization
1.91B
79 days until earnings call
Ad is loading...

AVXL vs IDYA

Header iconAVXL vs IDYA Comparison
Open Charts AVXL vs IDYABanner chart's image
Anavex Life Sciences
Price$8.35
Change-$0.33 (-3.80%)
Volume$1.14M
Capitalization710.29M
IDEAYA Biosciences
Price$21.85
Change+$0.12 (+0.55%)
Volume$1.02M
Capitalization1.91B
AVXL vs IDYA Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. IDYA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and IDYA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AVXL: $8.70 vs. IDYA: $20.44)
Brand notoriety: AVXL and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 62% vs. IDYA: 115%
Market capitalization -- AVXL: $710.29M vs. IDYA: $1.91B
AVXL [@Biotechnology] is valued at $710.29M. IDYA’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 4 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AVXL and IDYA are a good buy in the short-term.

Price Growth

AVXL (@Biotechnology) experienced а +4.95% price change this week, while IDYA (@Biotechnology) price change was -4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

AVXL is expected to report earnings on May 08, 2025.

IDYA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.91B) has a higher market cap than AVXL($710M). AVXL YTD gains are higher at: -18.994 vs. IDYA (-20.467). IDYA has more cash in the bank: 920M vs. AVXL (21.2M). AVXL has less debt than IDYA: AVXL (88.2K) vs IDYA (18.8M).
AVXLIDYAAVXL / IDYA
Capitalization710M1.91B37%
EBITDAN/A-220.54M-
Gain YTD-18.994-20.46793%
P/E RatioN/AN/A-
RevenueN/A3.92M-
Total Cash21.2M920M2%
Total Debt88.2K18.8M0%
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLIDYA
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 6 days ago
78%
Momentum
ODDS (%)
Bullish Trend 6 days ago
76%
Bearish Trend 6 days ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 6 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 13 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
73%
Aroon
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
78%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+2.11%
PLRX - AVXL
47%
Loosely correlated
-1.97%
NTLA - AVXL
46%
Loosely correlated
+7.76%
TENX - AVXL
45%
Loosely correlated
-1.81%
RXRX - AVXL
44%
Loosely correlated
+1.04%
IDYA - AVXL
41%
Loosely correlated
-2.67%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.67%
GRI - IDYA
54%
Loosely correlated
+0.87%
PRME - IDYA
47%
Loosely correlated
+5.28%
INAB - IDYA
47%
Loosely correlated
-8.18%
RCKT - IDYA
46%
Loosely correlated
+3.15%
ETNB - IDYA
46%
Loosely correlated
+3.31%
More